Genetic screening can inform women of their breast and ovarian cancer risks

Main|Search|PHGKB


Last Posted: Jul 06, 2018

---

• Genetic screening can inform women of their breast and ovarian cancer risks  
  L Abaid, LA Times, July 5, 2018
• Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis  
  N Fawcett, University of Michigan Health Lab Blog, July 3, 2018
• Bone loss in women with BRCA1 and BRCA2 mutations.  
  Powell C Bethan et al. Gynecologic oncology 2018 148(3) 535-539
• Clinicopathologic Characterization of Breast Carcinomas in Patients with Non-BRCA Germline Mutations: Results from a Single Institution's High Risk Population.  
  Meiss Alice E et al. Human pathology 2018 Jun
• Consideration of Population-Based BRCA Testing as a Strategy to Reduce Disparities in Genetic Counseling Referrals: The Importance of Stating (and Proving) the Obvious.  
  Newman Lisa A et al. JAMA surgery 2018 Jul
• Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.  
  Gill Jennifer et al. JAMA 2018 Jun 319(23) 2377-2378
• Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer  
  SJ Katz et al. JAMA Surgery, July 3, 2018
• Consideration of Population-Based BRCA Testing as a Strategy to Reduce Disparities in Genetic Counseling Referrals The Importance of Stating (and Proving) the Obvious  
  LA Newman, JAMA, July 3, 2018
• Development of Breast Cancer Choices: a decision support tool for young women with breast cancer deciding whether to have genetic testing for BRCA1/2 mutations.  
  Grimmett Chloe et al. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2018 Jun
• 23andMe's test for a breast-cancer gene can reveal life-changing information, but can also lead down an expensive and complicated path  
  A laVito, CNBC, June 2018

more